ARRY
Price
$5.90
Change
-$0.54 (-8.39%)
Updated
Jun 30 closing price
Capitalization
2.22B
42 days until earnings call
RPRX
Price
$36.02
Change
+$0.13 (+0.36%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
15.18B
36 days until earnings call
Interact to see
Advertisement

ARRY vs RPRX

Header iconARRY vs RPRX Comparison
Open Charts ARRY vs RPRXBanner chart's image
Array Technologies
Price$5.90
Change-$0.54 (-8.39%)
Volume$18.32M
Capitalization2.22B
Royalty Pharma
Price$36.02
Change+$0.13 (+0.36%)
Volume$78.78K
Capitalization15.18B
ARRY vs RPRX Comparison Chart in %
Loading...
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARRY vs. RPRX commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRY is a Buy and RPRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (RPRX: $35.87)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RPRX’s FA Score shows that 2 FA rating(s) are green while.

  • RPRX’s FA Score: 2 green, 3 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARRY’s TA Score shows that 5 TA indicator(s) are bullish while RPRX’s TA Score has 4 bullish TA indicator(s).

  • ARRY’s TA Score: 5 bullish, 4 bearish.
  • RPRX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ARRY is a better buy in the short-term than RPRX.

Price Growth

RPRX (@Biotechnology) experienced а +2.90% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.68%. For the same industry, the average monthly price growth was +32.84%, and the average quarterly price growth was +6.72%.

Reported Earning Dates

RPRX is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+3.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RPRX($15.2B) has a higher market cap than ARRY($2.22B). ARRY has higher P/E ratio than RPRX: ARRY (26.23) vs RPRX (14.70). RPRX YTD gains are higher at: 42.492 vs. ARRY (-2.318). RPRX has higher annual earnings (EBITDA): 2.02B vs. ARRY (276M). RPRX has more cash in the bank: 1.82B vs. ARRY (249M). ARRY has less debt than RPRX: ARRY (730M) vs RPRX (7.62B). RPRX has higher revenues than ARRY: RPRX (2.26B) vs ARRY (1.58B).
ARRYRPRXARRY / RPRX
Capitalization2.22B15.2B15%
EBITDA276M2.02B14%
Gain YTD-2.31842.492-5%
P/E Ratio26.2314.70178%
Revenue1.58B2.26B70%
Total Cash249M1.82B14%
Total Debt730M7.62B10%
FUNDAMENTALS RATINGS
ARRY vs RPRX: Fundamental Ratings
ARRY
RPRX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
1
Undervalued
PROFIT vs RISK RATING
1..100
10028
SMR RATING
1..100
10094
PRICE GROWTH RATING
1..100
5841
P/E GROWTH RATING
1..100
2857
SEASONALITY SCORE
1..100
n/a64

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RPRX's Valuation (1) in the Pharmaceuticals Major industry is significantly better than the same rating for ARRY (90) in the Biotechnology industry. This means that RPRX’s stock grew significantly faster than ARRY’s over the last 12 months.

RPRX's Profit vs Risk Rating (28) in the Pharmaceuticals Major industry is significantly better than the same rating for ARRY (100) in the Biotechnology industry. This means that RPRX’s stock grew significantly faster than ARRY’s over the last 12 months.

RPRX's SMR Rating (94) in the Pharmaceuticals Major industry is in the same range as ARRY (100) in the Biotechnology industry. This means that RPRX’s stock grew similarly to ARRY’s over the last 12 months.

RPRX's Price Growth Rating (41) in the Pharmaceuticals Major industry is in the same range as ARRY (58) in the Biotechnology industry. This means that RPRX’s stock grew similarly to ARRY’s over the last 12 months.

ARRY's P/E Growth Rating (28) in the Biotechnology industry is in the same range as RPRX (57) in the Pharmaceuticals Major industry. This means that ARRY’s stock grew similarly to RPRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARRYRPRX
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
67%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
58%
Momentum
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
49%
MACD
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
49%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
50%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
47%
Advances
ODDS (%)
Bullish Trend 20 days ago
80%
Bullish Trend 7 days ago
52%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 5 days ago
63%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
89%
Bearish Trend 4 days ago
74%
Aroon
ODDS (%)
Bullish Trend 6 days ago
70%
Bullish Trend 4 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AABPX12.000.04
+0.33%
American Beacon Balanced Inv
RINTX48.760.09
+0.18%
Russell Inv International Devd Mkts S
VEIEX31.29N/A
N/A
Vanguard Emerging Mkts Stock Idx Inv
BFGBX46.72N/A
N/A
BlackRock Capital Appreciation K
MUOIX31.35N/A
N/A
Morgan Stanley Instl US Core I

RPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RPRX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RPRX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPRX
1D Price
Change %
RPRX100%
+1.70%
AXON - RPRX
48%
Loosely correlated
+1.86%
MDGL - RPRX
31%
Poorly correlated
+0.41%
ARRY - RPRX
30%
Poorly correlated
-0.92%
DTIL - RPRX
30%
Poorly correlated
+3.86%
QURE - RPRX
29%
Poorly correlated
-2.60%
More